Evidence map›Paper›PMID 37176378›Full record

ArticleMaterials (Basel, Switzerland)2023

Cysteine as an Alternative Eco-Friendly Corrosion Inhibitor for Absorption-Based Carbon Capture Plants.

Mohamed Ishaq Habibullah, Amornvadee Veawab

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Turning Waste into Treasure: Invasive PlantMaterials (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mohamed Ishaq HabibullahFaculty of Engineering and Applied Science, University of Regina, Saskatchewan, SK S4S 0A2, Canada.
Amornvadee VeawabFaculty of Engineering and Applied Science, University of Regina, Saskatchewan, SK S4S 0A2, Canada.
University of Regina · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inorganic corrosion inhibitors are commonly applied to mitigate severe corrosion in absorption-based carbon capture plants. They are, however, not environmentally friendly, posing a health risk, harming the environment, and making chemical handling and disposal costly. Therefore, this study evaluated the corrosion inhibition performance of an amino acid, namely cysteine, with the aim of providing an eco-friendly alternative to the commercial inorganic corrosion inhibitors. Electrochemical and weight loss corrosion measurements showed that cysteine was effective in protecting carbon steel at all process operating conditions. At 80 °C, a 500 ppm cysteine could provide up to 83% and 99% inhibition efficiency under static and dynamic flow conditions, respectively. Its inhibition efficiency could be improved when the cysteine concentration, solution temperature, and flow condition were altered. Cysteine was an anodic corrosion inhibitor and underwent spontaneous, endothermic, and combined physical and chemical adsorption that followed the Langmuir adsorption isotherm model. The quantum chemical analysis indicated that cysteine had a high reactivity with metal surfaces due to its low energy gap and high dipole moment. The EDX analysis revealed a significant sulphur content on the metal substrate, indicating that cysteine's mercapto group played an integral role in forming an effective adsorption layer on the metal interface.

Indexed as

carbon captureCO2 absorptioncorrosion inhibitorcysteineelectrochemicalweight loss

Identifiers

PMID37176378
PMCPMC10179930
OpenAlexW4367624842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.